Multiple heterogeneous pathogen and self antigens

Multiple heterogeneous pathogen and self antigens refers to the vast array of molecular structures recognized by polyvalent immunoglobulin therapies, such as Intravenous Immunoglobulin (IVIG). These targets include diverse epitopes from pathogens like viruses and bacteria, as well as host-derived molecules such as autoantibodies, cytokines, and various cell surface receptors. In clinical use, drugs targeting these antigens provide passive immunity to immunodeficient patients and exert complex immunomodulatory effects in autoimmune and inflammatory conditions. The therapeutic benefit is achieved through the neutralization of infectious agents, the inhibition of pathogenic autoantibodies, and the modulation of immune cell activity via Fc receptor interactions. Because this target represents a broad functional category rather than a single protein, it characterizes the multi-target mechanism of action inherent to polyclonal antibody products.

Other names

Pathogen antigensSelf-antigensAutoantigensPolyvalent antigensIVIG targetsInfectious agent antigens

Polyclonal antibodies bind to and neutralize a wide variety of pathogen-derived antigens (viruses, bacteria) and host-derived self-antigens (autoantibodies, cytokines, and cell surface receptors), while also modulating Fc receptor signaling and complement activation.